TGF-β signaling in CAFs promotes the creation of physical and molecular barriers, which exclude CTLs from penetrating tumor nests and accessing cancer cells, thereby limiting effective anti-tumor immune responses[57,58]. Here, TGFB1 is linked to neoplasm.